Fractalkine CX3CL1 Rabbit Polyclonal Antibody (Carrier-free)

A 152E5.2 antibody; AB030188 antibody; ABCD 3 antibody; ABCD3 antibody; AI848747 antibody; C-X3-C motif chemokine 1 antibody; C3Xkine antibody; Chemokine (C-X3-C motif) ligand 1 antibody; Chemokine C X3 C motif ligand 1 antibody; Chemokine CX3C Motif Ligand 1 antibody; CX3C membrane anchored chemokine antibody; CX3C membrane-anchored chemokine antibody; CX3CL1 antibody; CXC 3 antibody; CXC3 antibody; CXC3C antibody; D8Bwg0439e antibody; FKN antibody; Fractalkine antibody; Neurotactin antibody; NTN antibody; NTT antibody; Processed fractalkine antibody; SCYD 1 antibody; SCYD1 antibody; Small inducible cytokine D1 antibody; Small inducible cytokine subfamily D (Cys X3 Cys) member 1 antibody; small inducible cytokine subfamily D (Cys-X3-Cys), member 1 (fractalkine, neurotactin) antibody; Small inducible cytokine subfamily D member 1 antibody; Small-inducible cytokine D1 antibody; X3CL1_HUMAN antibody

Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Mouse, Rat Immunohistochemistry (Frozen Section), 0.5-1μg/ml, Mouse, Rat, - Western blot, 0.1-0.5μg/ml, Mouse, Rat

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.